Azad Q1: PBT falls 7% YoY on capex costs despite 26% revenue growth; PAT gain tax-driven
PAT +19.46% YoY · revenue +25.9% · margins compressing
₹172.6 Cr
+25.9% YoY
₹35.16 Cr
+19.46% YoY
19.96%
-0.2pp YoY
₹5.53
Azad Engineering's consolidated revenue grew 25.9% YoY to ₹172.60 Cr in Q1 FY27 (June 30, 2026), just clearing management's FY27 guidance of 25%+ topline growth given on the Q4 FY26 call. However, consolidated PBT fell 6.9% YoY to ₹38.97 Cr (from ₹41.87 Cr), even as reported PAT rose 19.5% YoY to ₹35.16 Cr — a divergence driven entirely by a lower effective tax rate (9.8% vs 29.7% a year ago) on a ₹4.26 Cr deferred-tax credit this quarter. Adjusted for a normalized tax rate, underlying pretax profit was down roughly 7% YoY, not up ~20% as the headline PAT suggests.
Q1 FY-2027 vs prior quarters
The gap traces to costs below the operating line. Operating margin (revenue less materials, employee cost and other opex, before finance and depreciation) actually expanded to 37.3% from 35.9% YoY, so the core manufacturing business is running more efficiently. But finance costs jumped 74.6% YoY to ₹10.32 Cr and depreciation rose 83.6% YoY to ₹18.62 Cr, both consequences of the capacity build-out — the company has deployed ₹540.27 Cr of its ₹700 Cr QIP proceeds as of June 30, 2026, mostly toward capex. That pulled PBT margin down to 22.6% from 30.5% YoY, a ~790bps compression that operating efficiency gains couldn't offset. Sequentially, PAT eased 4.5% QoQ (₹36.81 Cr to ₹35.16 Cr) and NPM slipped to roughly 20.0% from 20.7%, a mild pullback after a strong Q4.
The stock went into the print at ₹2,489, up 0.5% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
What the summary numbers don't show
EPS (basic, consolidated) ₹5.53 for the quarter vs ₹5.57 in Q4 FY26 and ₹4.56 a year ago.
Management is confident in sustaining strong business momentum, projecting a top-line growth of approximately 25% plus for the current year (FY27) and on a multiyear basis. This growth is underpinned by the conversion of previously earned qualifications, newly commissioned capacity, and a robust order book. The company
— This quarter: met
No formal Street consensus estimates for this specific quarter turned up in a search — results returned data from the year-ago Q1 FY26 print instead — so vsStreet is unknown. Against management's own guidance (25%+ FY27 topline growth, normalizing the working-capital cycle), the revenue print is essentially on track, sitting right at the threshold. No standalone management press release accompanied this filing to cross-check against these figures. The quarter's other developments were largely non-financial: the board met the same day (Aug 7, 2026), the company delivered its first indigenous turbo jet engine to DRDO on July 22, 2026 (a qualification milestone, not a near-term revenue driver), and Rakesh Chopdar was reappointed Chairman & CEO on May 12, 2026 — continuity through this capex-heavy phase. Standalone results mirror the same dynamic (PBT down 5.5% YoY, PAT up 21.2% YoY on the same tax effect), so parent and group tell the same story.
W1
Effective tax rate: this quarter's 9.8% rate (vs FY26's ~29%) is unlikely to repeat — watch Q2 FY27 normalization and its drag on reported PAT growth.
W2
Finance cost and depreciation trajectory as the remaining ₹159.73 Cr of the ₹700 Cr QIP capex is deployed toward new capacity.
W3
Whether revenue growth holds at/above the 25%+ FY27 guidance given Q1 printed right at that threshold (25.9% YoY).
Strong Execution, But the Hard Part Starts Now
Revenue growth beat guidance, margins expanded to 37%, and turbojet engine delivery is real. Yet management held full-year guidance and sequential growth was just 6.8%. The street's quick fade signals skepticism on execution ahead.
25.9%
beat 25%+ guidance, on track
37.3%
vs guidance 32–35%, +150 bps YoY
+6.8%
from ₹161.6 Cr; not 'full throttle'
Held
25%+ growth, 32–35% margins; no raise
Azad delivered on all the headline numbers: ₹172.6 Cr revenue (+26% YoY), ₹35.2 Cr PAT (+19.5%), and 37.3% OPM — beating the 32–35% margin guidance by 2 percentage points. The turbojet engine, India's first indigenous expendable design, shipped to DRDO/MoD on July 22. Eight dedicated OEM plants are ramping at Tuniki Bollaram. Cost indigenization (raw material down from 12% to 5%) is proving sustainable. On paper, it's a solid quarter. But here's the tension: management did not raise full-year guidance despite beating, and sequential revenue growth was just +6.8% — not the 'full throttle' facility ramp they described. The street noticed: day-1 pop of +2.44% faded to flat (−0.38% by day 3). That fade is the market's own verdict.
Earnings quality: the numbers are clean, but the story is layered
No major MTM or forex windfall here. Other income was ₹4 Cr (normalized from ₹17 Cr in Q4 FY26 — a forex gain that won't repeat). The real story is that PAT growth (+19.5%) is muted compared to revenue growth (+25.9%). Why? Three deliberate headwinds: (1) Employee costs jumped 44% YoY (₹29 Cr → ₹42 Cr), management's acknowledged build for H2 ramp-up; (2) Inventory buildup for Q3–Q4 revenue (90–120 day work-in-progress cycles), dragging cash but not yet revenue; and (3) Working capital elevated at 170–180 days debtor days, with bill discounting costs embedded in P&L. Consolidated numbers are the fact; standalone is inflated by prior-quarter forex gains. Use the consolidated +19.5% as the organic baseline — it's cleaner and trails revenue growth, a sign of operational leverage still building.
Revenue growth 26% YoY, reached ₹172.6 Cr
Consolidated ₹172.6 Cr, +25.9% YoY — aligns with delivered result
Supported
EBITDA margins 37% with 150 bps expansion YoY
Delivered OPM 37.3%, consistent with cost indigenization and skill improvement
Supported
PAT grew 21% YoY (standalone)
Consolidated PAT ₹35.2 Cr, +19.5% YoY; standalone inflated by prior forex gain
Supported (use consolidated)
New Baker Hughes facility operational, 8 dedicated OEM plants in Tuniki Bollaram
April 2026 inauguration confirmed; revenue contribution expected H2 as ramp continues
Supported
Margins can sustain 32–35% guidance despite delivering 37%
Management conservative; credits cost indigenization + skill gains since inception (was 18–19% EBITDA). New capacity ramp-up could dilute margins if volumes miss.
Overstated (hidden caution)
India's first turbojet engine ready for production scale-up
Delivery confirmed July 22. Volumes unknown (2–4 digit range). Testing 4–6 weeks, then certification (timing TBD), then production ramp (6–12 months). Won't stabilize unit economics until 5–6 units produced.
Contradicted (volumes unquantified)
What changed on this call
Value chain elevation. Azad moved from cold-section gas turbine components (tier-1 supplier) to fully integrated defense propulsion systems (turbojet engine). TAM expands from component supplies to complete engine assemblies + defense platforms. Moats deepen via qualification barriers.
Cost structure breakthrough. Raw material costs fell from 12% to 5% via Sunflag/Star Wire onboarding (qualified globally, so multi-year benefit secured). That's 4–5% on transport + price. Sustainable, not a one-quarter win.
Capacity quantified for the first time. 8 dedicated OEM plants at Tuniki Bollaram, each generating ₹150–180 Cr at full utilization = ₹1,200 Cr peak revenue potential. Prior guidance was phased/vague; now it's a concrete number.
Guidance held despite beat — a yellow flag. Delivered 37.3% OPM, guidance 32–35%. Not raised. Conservative repositioning suggests management sees execution risk ahead or knows margin pressure is coming (employee absorption, WIP burn). Not a red flag, but a caution signal.
Engine monetization remains opaque. Volumes unknown ('2-digit, 3-digit, or 4-digit'). Won't know for 'next few weeks'. Testing 4–6 weeks, certification timeline TBD, production ramp 6–12 months. Margin costing not stable until 5–6 units. That's 3–4 months away minimum.
The market's view — price action and positioning
Stock was ₹2489 before the result (August 7). Day 1 pop: +2.44% (to ₹2551). By day 3, the move had faded to −0.38% — essentially back to flatness. That fade is deliberate. The market's own verdict: the print is solid execution, not a step-change. At ₹2665.1 now (as of August 13), the stock is +95.93% off its 52-week low (₹1360.2) and −0.89% from its all-time high (₹2689) — basically at peak valuation. Trend is bullish vs. all major moving averages (SMA20 ₹2409, SMA50 ₹2274, SMA200 ₹1850), but RSI 65.2 is neutral, signaling no overbought panic yet. Volume is increasing.
Ownership is shifting. FII trimmed from 14.75% (Q4 FY26) to 13.30% (Q1 FY27) — a 1.45 percentage point outflow despite the beat. DII also down 1.39pp. Promoter steady at 55.84%. The message: domestic institutions are adding, but foreign money is pulling back. At peak valuations with unproven upside (engine volumes TBD), that's rational. FII outflow despite solid execution is a yellow flag for valuation.
The debate
Risks, ranked by how much they should concern a holder
Execution complexity during simultaneous factory ramp, hiring, training, and new engine launch
HIGHVishnu flagged this as the #1 challenge. Tuniki Bollaram's 8 plants, 150–200 hires/month into 90-day training cycles, customer delivery pressures, and turbojet production ramp all colliding. High probability that one component fails or delays, dragging margin or revenue miss.
Turbojet engine monetization and volume uncertainty
HIGHDelivery confirmed July 22, but volumes unknown (2–4 digit range — that's a 200x difference). Testing 4–6 weeks, certification TBD, production 6–12 months out. Won't stabilize unit economics until 5–6 units. If DRDO/MoD process slower than guided, or if volumes come in 2-digit (vs 3–4 digit hopes), the structural TAM thesis is delayed 12–18 months and margin pressure from fixed cost absorption becomes acute.
Capacity utilization and margin compression as new facilities ramp
MEDIUMEight new OEM plants are underburdened. If customer demand softens (aerospace/defense cycle risk, Rolls-Royce delay, GE/Siemens slowdown) or engine scales slower than expected, utilization drops, fixed costs dilute, and OPM compresses from 37% toward guidance 32–35%. Sequential Q1 only +6.8%; if that repeats in Q2–Q3, fixed cost leverage erodes fast.
Working capital cash flow stress and FCF pressure
MEDIUMDebtor days 170–180, bill discounting costs embedded, employee costs elevated for buildup (won't normalize until Q3–Q4 production ramp). If H2 revenue overshoots and inventory/receivables bloat further, working capital target (160–180 days by H2) misses, and FCF pressure is real. Balance sheet health deteriorates.
Valuation and growth expectations gap
LOW-MEDIUMStock is at ATH, priced for step-change growth (implied 35%+ from engine + capacity). But guidance is 25%+ (unchanged), and sequential Q1 was only +6.8%. Market may compress multiple if H2 acceleration disappoints or if FII outflow accelerates (already −1.45pp). Not an immediate crisis, but downside risk is real if execution falters.
What to watch next
1 · Turbojet engine testing & certification timeline (Aug–Sep 2026 expected)
Management said 'we'll know in a few weeks' (after July 22 delivery). Any preliminary volume estimate or delay signal? Testing 4–6 weeks, but certification timeline is a black box. If DRDO/MoD process stretches beyond Q2, monetization slips into FY28, and engine impact is a 2027–28 story, not 2026. Watch for management commentary on weapon platform integration progress.
2 · Q2 FY27 sequential revenue growth (results expected Oct–Nov 2026)
Q1 was only +6.8% QoQ. Does facility ramp-up accelerate to 10%+ or stay flat? If sequential growth remains 6–8%, the 'full throttle' ramp narrative is overstated, and H2 acceleration is at risk. This is the single most important metric to track — it either validates or contradicts the entire H2 thesis.
3 · Rolls-Royce first batch delivery confirmation within Q1 FY27 (Aug–Sep 2026)
Management stated delivery is 'very soon, within this quarter.' Revenue recognition in Q1? Validates H2 inflection narrative or signals customer delay. Also watch for any guidance from management on Rolls-Royce volume/revenue contribution; this is your check on the civil aircraft engine ramp.
4 · Working capital progress: debtor days heading toward 160–180 days by H2?
Management targeting H1 ~200 days, H2 160–180 days. Current is 170–180. If H2 target is missed, it signals either demand surprise (good, but cash-hungry) or customer payment delays (warning). Bill discounting costs also key — elevated finance charges compress bottom-line if volumes miss. Track CFO commentary on receivables recovery and payment term negotiations.
The honest read
Azad is a high-quality execution story, but this quarter is a hand-off, not a breakout. FY26 proved the team can hit targets (Baker Hughes facility, margin expansion, cost indigenization). Q1 validated that momentum: 26% revenue growth, 37% OPM, turbojet engine delivery real. But sequential growth stalled at +6.8%, guidance wasn't raised, FII trimmed, and valuation is at ATH. The market's fade (day-1 +2.44% → day-3 −0.38%) is rational: good execution, but execution risk ahead.
The turbojet engine is structural and real. But it's 4–6+ months from meaningful revenue (testing, certification, production ramp 6–12 months). Volumes are a guess (2–4 digit range). The hard part — simultaneous factory ramp, hiring/training at scale, customer delivery, and engine production — starts now. Vishnu flagged execution complexity as the #1 challenge. Manufacturing history shows miss rates are high at this scale.
For holders: this is Hold. Quality execution, real tailwinds (defense/aerospace), but unproven upside and peak valuation. The number to track from here is sequential organic revenue growth — if Q2 is another +6–7%, the H2 acceleration thesis is a story, not yet a fact. Wait for Q2 results and turbojet volume guidance before reshuffling. For new money: price momentum is up (RSI 65, above all SMAs), but valuation is at ATH with binary event risk (engine volumes in 'next few weeks'). Not a buy yet. Wait for Q2 to prove H2 acceleration or for a 10–15% drawdown to reset sentiment.
Record engine milestone, 26% revenue growth, execution complexity ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Hit Q1 revenue guidance. Sustained 37% margins vs 25% FY26 guidance. But engine volumes unquantified; Rolls-Royce timing vague ('very soon'). FY29+ capex strategy deferred. Working capital still 170–180 days.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered solid 26% revenue growth and 37% OPM, beating modest 32–35% margin guidance. Turbojet engine milestone is a structural step-change (value chain elevation + addressable market expansion). However, H2 acceleration hinges on unproven capacity ramp-up and engine volume certainty (currently unknown: 2-digit to 4-digit). Near-term execution risk is material; long-term tailwinds (energy, defense, aerospace) are real. Management is confident but credibility tested only next call on volumes.
₹172.6 Cr
Revenue · +25.9% YoY₹35.2 Cr
Reported PAT · +19.5% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue growth 26.8% YoY, reached INR170.5 Cr standalone
METConsolidated revenue ₹172.6 Cr, 25.9% YoY, aligns with delivered result
EBITDA margins 37.6% with 150 bps expansion YoY
METDelivered consolidated OPM 37.3%; consistent with call narrative on cost indigenization benefits
PAT grew 21.2% YoY to ₹36.4 Cr standalone
METDelivered consolidated PAT ₹35.2 Cr, 19.5% YoY; standalone inflated by other income, consolidated is fact
New Baker Hughes facility operational, 7 dedicated OEM plants in Tuniki Bollaram
METConfirmed April 2026 inauguration; revenue contribution expected H2 as ramp continues
Margins can sustain 32–35% guidance despite delivering 37%+
OVERSTATEDManagement conservative; credits cost indigenization and skill improvement since inception (was 18–19% EBITDA). Risk: new capacity ramp-up could dilute if volumes miss.
India's first turbojet engine delivered to GTRE/MoD, ready for production scale-up
MISSDelivery confirmed July 22, 2026. Timeline to production volumes: 4–6 weeks to weapon platform testing, then certification, then production. Volumes unknown ('2-digit, 3-digit, or 4-digit'). Margin on units unquantified.
Earnings quality
What changed since the last call
Value chain elevation via turbojet engine manufacturing
UpgradeFrom component supplier tier to fully integrated propulsion system player. TAM expands from cold-section gas turbine components to complete engine assemblies + defense applications. Moats deepen via qualification barriers.
Capacity expansion pace accelerated
Upgrade8 dedicated OEM plants at Tuniki Bollaram, each generating ₹150–180 Cr at full utilization = ₹1,200 Cr potential. Civil construction on track to wrap by FY27-end. Prior guidance was phased, undefined; now quantified peak revenue.
Cost structure improved via indigenization
UpgradeRaw material costs down from 12% to 5% via Sunflag/Star Wire onboarding (saved 4–5% on transport + price). Sustainability: Sunflag/Star now qualified globally, securing multi-year benefit.
Margin guidance held despite beat
NeutralDelivered 37.3% OPM, guidance 32–35%. Not raised. Conservative positioning suggests mgmt sees volume execution risk or knows H2 margin pressure incoming (employee absorption, WIP burn). Risk flag.
Engine volumes remain opaque
WithdrawnPrior call likely implied scale potential. Q1 call admits volumes unknown ('2-digit, 3-digit, or 4-digit'). Won't know for 'next few weeks'. Production timeline: 4–6 weeks to certification, then ramp (6–12 months to 20-unit status). Monetization delayed.
The Q&A
Analysts pressed on growth vs. global peers (Howmet 50% EBITDA growth), margin sustainability (37% vs guidance 35%), capex roadmap (FY29+), and rupee benefit. Management held steady: scale/maturity differ; new capacity is the lever; capex to be detailed next call. Some evasion on investment casting opportunities ('difficult to comment on call').
Turbojet engine roadmap — Vikas Singh, ICICI Securities
Partial4–6 weeks to weapon platform testing, then certification, then production. Volumes unknown (2-, 3-, or 4-digit); 2-digit can be handled in existing capacity; higher volumes require planning. Know details in next few weeks.
Hot section strategy & OEM pipeline — Amit Dixit, Goldman Sachs
PartialMitsubishi facility (hot section) 7–8 months away; model replicable for other OEMs. Market is 'billion-dollar story, only 2–3 players globally.' Azad will crack it. Margins in high-cost countries (US/Europe) are healthy; India advantage obvious. No specific guidance on Azad's trajectory.
Margin sustainability — Gaurav, Avendus
DodgedSkill set, process engineering, continuous improvement since inception (was 18–19%). Guidance stays 32–35% for calculation/conservatism. Delivered above, but not updating guidance yet. Magic on the floor will continue.
Engine project margins and timelines — Subhi Gupta, Trinetra Asset Managers
AnsweredCannot cost out first engine; need 5–6 units in sequence (8–12 weeks or 3–4 months). Rolls-Royce first batch delivery very soon, within this quarter.
Asset base and revenue potential — Aditya Bhartia, Investec
Partial8 plants each generate ₹150–180 Cr at full capacity = ₹1,200 Cr total. Civil construction finish FY27-end, ramp-up continuous. H2 acceleration expected. Currently guiding 25%+ because 'we know our situation'; as we shift to next level, guidance will change. No formal 35% target disclosed.
Foreign exchange benefit & organic growth — Aditya Bhartia, Investec
AnsweredRupee benefit ~5–6%, but not a primary planning lever. Co-imports mean natural hedge. Revenue growth is capacity-driven, not forex-driven.
Capex roadmap post-FY27 — Kamlesh Bagmar, Lotus Asset Managers
DodgedCurrent plant ramp and capacity deployment phased to contracts. Major capex from FY29 onwards (not quantified). Opportunities across sectors being evaluated; will update next quarter.
Talent and culture — Prateek Shrivastava, Nivesh Wisdom
AnsweredHiring 150–200/month; 90-day training programs. Founder culture from 'high school dropper' building advanced company. Continuous skilling, shadowing model. Bench strength intentionally overstaffed for future deployment.
P&L efficiency drivers — Basant Bansal, NBG Investment
AnsweredRaw material: Sunflag/Star Wire qualified domestically, 4–5% transport + price benefit. Sustainable. Employee costs: Deliberate WIP buildup for Q3–Q4 revenue (90–120 day cycles); will normalize Q3 onwards.
Key challenges ahead — Basant Bansal, NBG Investment
AnsweredExecution complexity: simultaneous factory build, hiring, training, production ramp, customer delivery. Stretching all pieces together. No single showstopper; all must work in concert.
Guidance
Long-term annual revenue growth over 25%
HighReiterated on call. Anchored by firm order book, multi-year contracts (5–7 year visibility with global OEMs), and structural tailwinds (energy security, defense self-reliance, aerospace demand).
H2 FY27 acceleration from new capacity ramp
Medium80% of expansion stabilized Q1; remaining by mid-Q2. Machine ramp-up ongoing 'at full throttle'. Revenue inflection expected Q3 onwards. Unproven; sequential Q1 was only +6.8%.
Turbojet engine production scale-up in coming months after testing (4–6 weeks) and certification
LowVolumes unknown (2-, 3-, 4-digit scenarios). Won't know details for 'next few weeks'. Timeline vague; production ramp could take 6–12 months to stabilize.
EBITDA margins 32–35% long-term guidance window
HighHeld since prior call. Delivered Q1 37.3% OPM. Management says guidance is conservative for 'calculation purpose'; actual delivery will likely exceed. Cost indigenization sustainable; skill improvements ongoing since inception.
Margin expansion from operating leverage as capacity utilization rises
MediumNew facilities currently under-utilized. Full ramp-up expected by end of FY27. Risk: if engine volumes miss or new customer ramp delays, margin leverage erodes.
FY27 capex to complete civil construction at Tuniki Bollaram Center of Excellence
HighOn track for end-of-FY27 wrap-up. Machine installation phased. Existing capacity sufficient for next 2 years of contracted revenue.
Major capex from FY29 onwards (not quantified)
LowManagement deferred detailed FY29+ roadmap to next quarter. Will depend on engine production success and pipeline win rate.
Risks the call surfaced
Execution complexity during ramp
HighSimultaneous factory construction, hiring 150–200/month, 90-day training cycles, customer delivery, and new product (turbojet engine) launch. Vishnu flagged this as primary challenge. High chance of margin dilution or delivery misses if any component fails.
Turbojet engine monetization delay
HighFirst engine delivered July 22, 2026. Volumes unknown (2–4 digit scenarios). Timeline to production orders: 4–6 weeks testing + certification (weeks/months unknown) + stable production (6–12 months). Margin costing not stable until 5–6 units. If volumes disappoint or ramp takes 18+ months, TAM expansion thesis delayed.
Working capital and cash flow stress
MediumDebtor days 170–180, reflecting long aerospace/defense payment cycles. Bill discounting facility creates finance cost drag embedded in P&L. If H2 revenue ramp overshoots and inventory/receivables bloat, cash conversion cycle could extend beyond H2 target (160–180 days). FCF at risk if working capital management misses.
Capacity utilization risk and margin compression
MediumNew facilities (8 plants, ₹1,200 Cr peak capacity) currently ramping. If customer demand softens or new product (engine) scales slower than expected, utilization drops and fixed cost absorption worsens. Sequential Q1 showed only 6.8% revenue growth; if H2 miss occurs, OPM could compress from 37% toward guidance 32–35%.
Guidance conservatism / growth expectations gap
LowManagement guiding 25%+ long-term growth and 32–35% margins, but delivering 26% revenue and 37% OPM. Delivered 8.3% sequential (standalone) but consolidated only 6.8%. If market expects more aggressive guide post-engine milestone, miss could trigger multiple compression despite solid execution.
Management
Score 8/10. Clear and structured. Chopdar sets macro context; Jajoo walks detailed P&L; Vishnu frames strategy. Self-corrected in-call errors (consolidated revenue ₹122.6 → ₹172.6; A&D growth 38.4% → 24.7%). Transparent on unknowns (engine volumes, capex roadmap deferred). Some evasion on investment casting opportunity ('difficult to comment on call'). Strong track record on FY26 milestones: Baker Hughes facility (April 2026), capacity expansion, cost indigenization (Sunflag/Star Wire onboarding). Q1 hit revenue guidance. Margins sustained 37% vs. 35%+ consistently. BUT: new ventures (engine, hot section) unproven in revenue scale; sequential growth only 6.8% vs. parallel claims of 'full throttle' ramp.
1 · Aug–Sep 2026
Turbojet engine weapon platform testing, certification phase
2 · Q2 FY27 (Aug–Sep)
First batch Rolls-Royce civil aircraft engine qualification parts delivered
3 · Q3–Q4 FY27
H2 revenue inflection from new facility ramp-up and first engine production units
Management is confident but credibility tested only next call on volumes.